SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vivus: into single digits
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: MIKE DUBIS who wrote (769)8/11/1998 7:37:00 PM
From: VLAD  Read Replies (1) of 1016
 
MIKE,

There is the truth and then there is the lie. The short interest has constantly attempted to give the impression that MUSE does not work or that the company is going out of business. Look at Assensio's total bs press release back in December. The information was produced so that the uninformed investor would believe that MUSE does not work. Look at the bias study presented at the AAU meeting and how the short interest made sure that the biased information came out on TV etc. as if it were valid. I could go on but I will not. MIKE, mark my words that Viagra has already seen its best days and will eventually be Pfizer's nightmare. In the short term things do not "appear" rosey for Vivus--especially its manipulated stock price. In the long term it will all come out in the wash.

VLAD

PS Bookmark this post.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News